Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1711-1712, 2003; 10.1373/49.10.1711
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mariën, G.
Right arrow Articles by Bossuyt, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mariën, G.
Right arrow Articles by Bossuyt, X.
Related Collections
Right arrow Clinical Immunology
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2003;49:1711-1712.)
© 2003 American Association for Clinical Chemistry, Inc.


Letters

Response to the Comments of K. Day and J. Zakowski on "Clinical Capillary Zone Electrophoresis of Serum Proteins: Balancing High Sensitivity and High Specificity"

Godelieve Mariën and Xavier Bossuyta

Laboratory Medicine and Immunology, University Hospital Leuven, Herestraat 49, B-3000 Leuven, Belgium

aAuthor for correspondence.

The first 20% of the full text of this article appears below.


To the Editor:

We wish to respond to the comments of K. Day and J. Zakowski concerning our letter in the August issue of Clinical Chemistry (1)(2) in which we discussed the capabilities of agarose gel electrophoresis/immunofixation and capillary zone electrophoresis for detecting rare monoclonal proteins.

We first wish to respond to their comments that enhanced resolution often detects peaks that previously were not readily observable, that the gamma zone migrates more rapidly in CZE Version 1.6.02 and may be misinterpreted as a peak . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
I. Infusino, P. Luraschi, M. Panteghini, and C. Franzini
Pretreatment of serum with penicillamine: effects on capillary electrophoresis patterns and on immunonephelometric measurement of immunoglobulins.
Clin. Chem., April 1, 2006; 52(4): 772 - 774.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Luraschi, I. Infusino, I. Zorzoli, G. Merlini, C. Fundaro and, and C. Franzini
Heavy Chain Disease Can Be Detected by Capillary Zone Electrophoresis
Clin. Chem., January 1, 2005; 51(1): 247 - 249.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
X. Bossuyt and G. Marien
False-Negative Serum Protein Electrophoresis in a Sample with an IgM Monoclonal Protein by Semiautomated Gel Electrophoresis
Clin. Chem., January 1, 2005; 51(1): 270 - 270.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.